ORAMED PHARMACEUTICALS INC. (ORMP)

5.02 -0.20% (-0.01)

Over 1M: +14.4%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

4.5 5
3 Aug 6 Aug 11 Aug 14 Aug 19 Aug 24 Aug 27 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '25 — Gross Profit: 0 Q3 '25 — Operating Cash Flow: -1.6M Q3 '25 — Free Cash Flow: -1.6M Q4 '25 — Gross Profit: 0 Q4 '25 — Operating Cash Flow: -466K Q4 '25 — Free Cash Flow: -468K Q1 '26 — Operating Cash Flow: -2.9M Q1 '26 — Free Cash Flow: -2.9M Q2 '26 — Operating Cash Flow: -200K Q2 '26 — Free Cash Flow: -202K -2.4M -1.8M -1.2M -600K 0
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Gross Profit Operating Cash Flow Free Cash Flow

Figures as at 2025-12-31, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 306.6%
OE margin -567.4%
Oper. margin -726.2%
ROIC -3.8%
ROA 47.3%
ROE 55.1%
Accruals 48.7%
Asset turnover 0.0054×
EBITDA margin -720.1%
FCF margin -260.8%
Gross margin 0.65%
OCF margin -260.3%
ROCE -4.0%
OCF / EBIT —
Profit margin —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.5
RPO / sales 0.85×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Interest cover -17.0×
Cash / Debt 24.7×
Debt / Eq 0.0021×
Debt payback 0.0 yr
Payout 6.0%
Quick ratio 5.0×
Cash runway 3.0 yr
F-score 5.1 pts

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.8
Sales/sh Y/Y +43.7%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales Q/Q —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.